EINECS 200-291-6
EINECS 200-291-6 Brand names, EINECS 200-291-6 Analogs
- (+)-Aspartic acid
- (2S)-Aspartic acid
- (L)-ASPARTIC ACID
- (S)-Aminobutanedioic acid
- (S)-Aspartic acid
- 4-04-00-02998 (Beilstein Handbook Reference)
- AI3-04461
- Acide aspartique [INN-French]
- Acido aspartico [INN-Spanish]
- Acidum asparticum
- Acidum asparticum [INN-Latin]
- Aminosuccinic acid
- Asparagic acid
- Asparagic acid (VAN)
- Asparaginic acid
- Asparaginic acid (VAN)
- Asparaginsaeure [German]
- Aspartate
- Aspartate, L-
- Aspartic Acid [USAN:INN]
- Aspartic acid
- Aspartic acid (VAN)
- Aspartic acid, L-
- Aspatofort
- BRN 1723530
- Butanedioic acid, amino-, (S)-
- CCRIs 6181
- EINECS 200-291-6
- FEMA No. 3565
- H-Asp-OH
- HSDB 1430
- L( )-Aminobernsteinsaeure
- L-(+)-Aspartic acid
- L-2-Aminobutanedioic acid
- L-Aminosuccinic acid
- L-Asparagic acid
- L-Asparaginic acid
- L-Asparaginsaeure
- L-Asparaginsyra
- L-Aspartic acid
- L-Aspartinsaeure
- NSC 3973
EINECS 200-291-6 Brand Names Mixture
- No information avaliable
EINECS 200-291-6 Chemical_Formula
C4H7N1O4
EINECS 200-291-6 RX_link
No information avaliable
EINECS 200-291-6 fda sheet
EINECS 200-291-6 msds (material safety sheet)
EINECS 200-291-6 Synthesis Reference
No information avaliable
EINECS 200-291-6 Molecular Weight
133.104 g/mol
EINECS 200-291-6 Melting Point
230 oC
EINECS 200-291-6 H2O Solubility
4.5 g/l
EINECS 200-291-6 State
Solid
EINECS 200-291-6 LogP
-0.67 +/- 0.36
EINECS 200-291-6 Dosage Forms
Capsules and powder
EINECS 200-291-6 Indication
There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
EINECS 200-291-6 Pharmacology
L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.
EINECS 200-291-6 Absorption
Absorbed from the small intestine by an active transport process
EINECS 200-291-6 side effects and Toxicity
Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.
EINECS 200-291-6 Patient Information
No information avaliable
EINECS 200-291-6 Organisms Affected
Humans and other mammals
